Introduction {#Sec1}
============

The importance of sustained support over extended periods of time is particularly important for patients, especially for rehabilitation, chronic diseases, or other conditions such as those affecting cancer survivors. In these situations, patients are often left at home, expected to continue their lives and activities, while dealing with potential complications and issues inherent to their health conditions \[[@CR27]\]. To support them effectively in this delicate phase, healthcare providers need to have a sufficient understanding of the individual pathways of each patient, as well as the potential risks and courses of action \[[@CR19]\]. Each patient may respond differently to treatments, depending on a series of factors, including demographics, health conditions, psychological aspects, social and emotional characteristics, etc. Although it is undoubtedly complicated and even expensive to have such a detailed picture of each patient's situation using traditional approaches, nowadays, the use of digital solutions for personal data monitoring and coaching opens the ways for personalized healthcare. Such solutions include the usage of artificial intelligent (AI) techniques ---including machine learning (ML) based data analytics--- through the exploitation of large volumes of personal health data acquired from patients going through different health pathways.

The concept of illness trajectories \[[@CR31]\], describing the different events and situations a patient experiences through a given illness, can be broadened to what is called a patient trajectory \[[@CR3]\]. Beyond the scope of an illness, a patient trajectory encompasses contextual data from the patient, even before diagnosis, and may include multiple co-morbidities, as well as emotional and social indicators, self-reported outcomes, and wellness monitoring observations during and after treatment \[[@CR14], [@CR41]\]. The usage of data analytics based on ML techniques applied to this vast body of data can provide a number of features including: patient stratification, identification of unusual behavior patterns, prediction of wellness and distress parameters, assessment of home exercise performance, improvement of adherence to treatment, identification and prevention of risk situations. On the one hand, the information contained in these trajectories requires managing and integrating (potentially) very diverse types of data, ranging from electronic health records \[[@CR8], [@CR18]\] to self-reported observations \[[@CR20]\] or sensor measurements recorded by a wearable device \[[@CR10]\]. The data *variety* and *distribution* aspects are, therefore, fundamental problems to be addressed. On the other hand, as a consequence, the management of this information requires taking into account specific concerns regarding data *distribution*, reuse conditions, sharing among different care structures, confidentiality & privacy. In particular, the agent-oriented approach characterizes the majority of assistive systems operating with distributed and heterogeneous data \[[@CR12]\]. Agent-based systems can ensure a high-degree of personalization \[[@CR4]\], autonomy, distributed collaborative/competitive intelligence, and security.

Therefore, in the context of patient trajectory analytics, the main high-level requirements are: to handle broad-scope information, heterogeneous data-sources, and distributed data producers and consumers. These requirements entail scientific challenges related to (i) the modeling of patient trajectories under heterogeneity constraints; and (ii) the design of decentralized digital infrastructures for analyzing and sharing these trajectories. In this paper, we propose addressing these two challenges by introducing an agent-based modeling approach that relies on the use of semantic modeling of patient trajectories. The rationale behind this design is that ontology models can effectively help to describe events and circumstances of a patient with respect to her health condition, while autonomous agents can represent her interests facing other agents, which may act on behalf of other patients, healthcare providers, and data analytics processes. The agent paradigm, in this case, guarantees that patients (through their agents) can establish and negotiate how and what data is collected from them, which data sources can be considered, which data is shared and with whom, or what kind of processing is allowed. In the same way, healthcare professionals may request through their agents, what kinds of data are requested form a patient trajectory, which kind of data analytics are necessary, and what other collaborations or cooperation mechanisms are needed with other physicians, nurses or other personnel.

The main contributions of this work can be summarized as follows: we (i) identify the main challenges for decentralized analytics of patient trajectories ("[Challenges in patient trajectories: Modeling and analytics](#Sec3){ref-type="sec"}"); (ii) establish a set of design principles of agent interaction models for patient trajectories represented through ontologies ("[Patient trajectory agents: Design principles](#Sec4){ref-type="sec"}"); (iii) propose a multi-agent architecture that complies with those principles ("[Agent-based architecture for patient trajectory management](#Sec5){ref-type="sec"}"); and (iv) provide an example of how this approach can be applied in the context of cancer survivor trajectories ("[Case study scenario: Trajectories of cancer survivors](#Sec2){ref-type="sec"}" and "[Cancer survivors support with τ Agents](#Sec6){ref-type="sec"}").

Case study scenario: Trajectories of cancer survivors {#Sec2}
=====================================================

Cancer is one of the main causes of death worldwide, and diagnosed cases are expected to increase significantly in the next decades \[[@CR9]\]. Although the different forms of cancer affect a large portion of the population, including millions of patients in working age, recent advances in early detection and treatment are already showing promising results \[[@CR34]\]. In Europe, more than 50% of cancer patients survive five years or more after diagnosis, and a number of them are able to return to work and daily life activities, although experiencing side-effects and other conditions due to their treatment \[[@CR29]\]. These patients endure different physical and psychological issues after cancer treatment has ceased, potentially during long-term periods. These issues are known to affect the quality of life (QoL) significantly and include reduced physical activity, increased fatigue, fear of cancer recurrence, emotional distress, etc. \[[@CR24], [@CR38]\]. Although there is evidence that specific changes in behavior can lead to better outcomes for survivors \[[@CR21]\] --e.g., changes in diet, moderate exercise, cognitive therapies-- in practice, it is difficult to adapt these recommendations to individual needs, preferences, expectations, and motivation factors.

Understanding the trajectory of cancer survivors can constitute a fundamental starting point in order to provide useful and personalized suggestions or support \[[@CR26]\]. Trajectory information can be acquired from several sources, including the EHR of each patient, self-reported information, behavior questionnaires, or wearable data. Events in the trajectory can be used to identify associations between symptoms, and events, such as therapies, interventions, admissions, re-admissions, etc. (Fig. [1](#Fig1){ref-type="fig"}). Trajectories can be used to assess risks as well as to establish predictive models associating symptoms, diseases and outcomes. As we can see in Fig. [1](#Fig1){ref-type="fig"}, the trajectory of a patient has a direct incidence not only on her physical well-being but also on the social and psychological aspects of her life. Therefore, the trajectory information can help coping with disease sequels and issues affecting physiological and physical characteristics, while also supporting a broader scope of quality of life aspects. Fig. 1Schematic view of a patient trajectory over time, with respect to general well-being and distress. Notice that the trajectory can be analyzed for different aspects, e.g. physical, psychological, social

An additional difficulty for managing cancer survivor trajectories is the need to share data among different institutions and entities, entailing an inherently distributed scenario, while guaranteeing privacy requirements. Survivors are generally at home, and a lot of the information produced at this point is acquired through apps, self-reported outcomes and other instruments. Moreover, EHR data may come from different hospitals and clinics where the patient was treated, e.g. for chemotherapy, physiotherapy, radiotherapy, or surgery, even in different geographical locations. Without coordination mechanisms, the patient is left with the burden of managing her own data, and having to use ad-hoc procedures for sharing it among clinical and medical professionals.

Challenges in patient trajectories: Modeling and analytics {#Sec3}
==========================================================

The modeling of patient trajectories is not straightforward, given the diversity of information sources, and the broad scope of data that they may include, from demographics to physiological or psychological observations. We can summarize these challenges according to the following aspects:

Trajectory information heterogeneity {#FPar1}
------------------------------------

A fundamental issue for the modeling of trajectories is related to the vast number of information that can potentially be integrated. Depending on the objectives of the analytics to be performed, trajectories must be able to include different types of data. For example, in Table [1](#Tab1){ref-type="table"}, we identify items form EHR and other sources that could be relevant for the trajectory of a cancer survivor \[[@CR14], [@CR41]\]. The degree of heterogeneity requires the usage of models that incorporate semantics, potentially spanning very different aspects: diagnostics, treatments, medication, laboratory, imaging, quality of life, etc. Table 1Relevant aspects for patient trajectories of cancer survivors from different sourcesAspectsPotential parametersSourceDemographicsage, gender, marital status, employment, etc.EHRGeneral indicatorsBMI, weight, height, blood pressure, etc.EHR +MonitoringDiagnosisCancer type, disease stage, tumor location,EHRtime after diagnosis, etc.Treatmentsurgery, ostomy, radiation, chemotherapy, etc.EHRCo-morbiditieshypertension, diabetes, CVD, chronic lung disease,EHRhigh cholesterolSymptom burdenfatigue, sleep disturbances, depression, pain,Self-reported +cognitive dysfunction, insomniaMonitoringQuality of lifephysical, psychological and social functioningSelf-reported

Patient data sources {#FPar2}
--------------------

Trajectory information may be acquired from different repositories and devices. Models must define interaction mechanisms for acquisition, negotiation, and exchange of trajectory data from heterogeneous sources (see Table [1](#Tab1){ref-type="table"}). For example, cancer survivor data may include retrospective information extracted from EHR records in one or more hospitals and clinics. It may also comprise continuous measures from a wearable device (e.g., for physical activity), or even chatbot interactions and questionnaire responses (e.g., emotional assessment).

Trajectory data integration & aggregation {#FPar3}
-----------------------------------------

In order to analyze trajectories, it is necessary to combine not only different data sources but also from large numbers of patients. Using machine learning or other AI techniques, it is then possible to extract relevant insights, derive patterns, and classify trajectory trends. The acquisition of these data requires protocols for establishing the conditions on which data will be used, how it will be processed, and what outcomes might be obtained.

Life-long dynamic trajectories {#FPar4}
------------------------------

Trajectories can span several years, and may also include live data collected daily (or instantaneously) through sensing devices. Trajectory analysis must be able to cope with this dynamicity and incorporate on-demand analytics that adapts through time and according to the evolution of the patient pathway. For example, trajectory predictions can help dramatically improving quality-of-life indicators in cancer survivors.

Data analytics explainability {#FPar5}
-----------------------------

Although AI-based analytics have shown impressive results for classification, prediction, and pattern identification, they often lack in terms of understandability and interpretability. Patient trajectory analytics should be able to provide explainable outcomes, potentially combining and reconciling complementary predictors. In particular, for cancer survivors explanations can lead to stronger motivation and self-efficacy regarding a therapy or treatment.

Privacy and confidentiality {#FPar6}
---------------------------

Given the sensitive nature of trajectory data, privacy has to be guaranteed along the process of acquisition, exchange, processing, and storage. Following current regulations in privacy (e.g., GDPR in the EU), patients' rights must be respected, e.g., granting access to selected data, accepting or rejecting consent conditions, deleting personal data partially/entirely, or obtaining one's personal data collections.

Patient trajectory agents: Design principles {#Sec4}
============================================

To address the challenges described in "[Challenges in patient trajectories: Modeling and analytics](#Sec3){ref-type="sec"}", we propose the representation of trajectories using semantic models and embedding interactions in a multi-agent environment according to the following design principles.

Ontology-based trajectory modeling {#FPar7}
----------------------------------

Our model proposes using ontologies to represent trajectories, as well as connected aspects, including illnesses, admission/discharge events, periodical observations, diagnosis, etc. As a result, trajectories can be represented as knowledge graphs with precise semantics and upon which reasoning and analytics can be applied \[[@CR6], [@CR7]\]. The advantages of using ontologies are numerous, as they provide semantics-by-design, allow overcoming heterogeneity, facilitate the interconnection of diverse sources, and can be used as the backbone of logic-based reasoning. In particular, this paper focuses on the use of the widely used schema.org \[[@CR22]\] vocabulary (see Fig. [2](#Fig2){ref-type="fig"}), which contains a set of medical concepts related to trajectory aspects, including symptoms, medical conditions, therapies, diagnosis, etc. Fig. 2Excerpt from schema.org \[[@CR22]\] of relevant medical concepts for patient trajectories. For simplicity, empty boxes represent unspecified types

Standard semantic vocabularies {#FPar8}
------------------------------

Several ontologies have been standardized, especially in the health domain. These include medication standards, laboratory codes, diagnosis, biomedical concepts, among many others. Moreover, generic health vocabularies, such as the schema.org medical terms, can be used to have a common way of referring to trajectories and their related concepts. Our architecture, as seen later, is based on the use of standard semantic models, i.e., RDF and ontologies in the health domain. As seen in Fig. [2](#Fig2){ref-type="fig"}, the popular schema.org vocabulary contains standard terms, which can be complemented with specific medical ontologies like MeSH \[[@CR32]\] or ICD-10 \[[@CR33]\]. Moreover, as seen in Fig. [3](#Fig3){ref-type="fig"}, we can use these terms to represent the different events and stages in the patient trajectory, e.g., symptoms, therapies, surgical procedures, conditions, etc. Fig. 3Schematic view of a patient trajectory, aligning with schema.org medical concepts: symptoms, conditions, therapies, surcial procedures, etc

Agent-based entity modeling. {#FPar9}
----------------------------

The multi-agent paradigm enables decentralized interactions among entities concerned with patient trajectories. These include the patient itself, which includes her behaviors, goals, and knowledge. Data acquisition processes can also be modeled as agents, coordinating trajectory building with other agents that implement analytics processing, confidentiality negotiation, or aggregation on behalf of a clinical institution (e.g., for a research study). We propose modeling all entities intervening in the generation, processing, and consumption of trajectory information.

Multi-agent behaviors for trajectory interactions {#FPar10}
-------------------------------------------------

Interactions among agents managing trajectories can be governed through dynamic behaviors, considering changes that may occur during the period of observation or study. These behaviors may include ML or other AI-based processing of trajectory data; or in a meta-level, the negotiation of exchange of trajectories. Regarding data aggregation, the behavior of an agent representing a clinical study may require managing interactions within a cohort of patients or the request for crowd-sourced data. In all of these, the decentralized nature of these behaviors makes it possible to avoid top-down governance schemes, which are unfeasible in multi-party clinical studies and support environments.

Negotiation in trajectory processing {#FPar11}
------------------------------------

The multi-agent paradigm includes the possibility of incorporating negotiation mechanisms at different levels of trajectory analysis. For example, a processing agent using ML techniques may require detailed EHR records for training, which could potentially clash with a patient agent's goal regarding data anonymity. A negotiation could be established to comply with both parties' expectations. Other negotiation protocols can be set up, for instance, by coaching agents, which may propose different treatment strategies to a patient agent. A dialogue between the two parties can then be established in order to agree on the most suitable strategy to follow jointly. Our model considers these negotiation patterns a fundamental element in the decentralized management of patient trajectories.

Personal data privacy interactions {#FPar12}
----------------------------------

Agents must be designed to comply with existing regulations for data privacy (e.g., GDPR). In this regard, it is fundamental to consider semantic models representing personal data handling concepts, including consent, purpose, processing, legal basis, controllers, and recipients, among others \[[@CR36]\]. Agents can, therefore, exchange patient trajectory data, only if consent requirements are met, and according to the legal constraints reflected with these semantic vocabularies.

Agent-based architecture for patient trajectory management {#Sec5}
==========================================================

This section presents a conceptual architecture of an agent-based approach for patient trajectory management, relying on the use of ontology-driven data models. The central element in this architecture is the *τ* Agent, which s a patient trajectory management agent (Fig. [4](#Fig4){ref-type="fig"}). Agents of this type can play different specific roles, such as a patient agent, a processing agent, coaching agent, aggregator agent, and acquisition agent. A *τ* Agent is characterized by a set of goals, beliefs, and behaviors; and includes a specialized knowledge graph of patient trajectory data (partial, complete and/or aggregated). Moreover, it employs a set of channels for communication with other *τ* Agents, a scheduler for establishing task allocation strategies, a set of standard ontologies for trajectory and medical data representation, and (optionally) a set of ML analytics components. Fig. 4Schematic view of *τ* Agents for managing patient trajectories

*τ* Agent goals may differ according to the assumed role \[[@CR39]\]. For a patient *τ* Agent, the goals may be related, for instance, to quality of life indicators. For example, a goal of an agent acting on behalf of cancer survivor, could be to retain moderate physical activity over a certain period, in order to reduce risk factors of recurrence. Conversely, a coaching agent may define goals regarding the adherence of its assigned patients to their individual treatments or therapies. This could be measured using different indicators, e.g., through quantitative instruments.

Similarly, beliefs can be defined differently according to the agent role. In general, beliefs include metadata of other agents (e.g., patient agents subscribed to a coaching agent, or potential trajectory contributors for training a ML agent), health vocabularies, constraints, and privacy policies. These beliefs can be crucial later on, for example, during a negotiation among different agents. For instance, a coaching agent belief set can be periodically updated in order to follow the evolution of a patient trajectory, so that future support actions are adapted to the current situation. Behaviors may require access to different functionalities. In the case of processing *τ* Agents, this may include gateways for machine learning methods or reasoning over the trajectory knowledge graphs. All communication channels in *τ* Agents use RDF \[[@CR16]\] as underlying representation model (Figs. [4](#Fig4){ref-type="fig"} & [5](#Fig5){ref-type="fig"}). Fig. 5Interactions among *τ* Agents assuming different roles. All interactions rely on the usage of semantic RDF messages

In Fig. [5](#Fig5){ref-type="fig"} we provide a detailed example of interactions among *τ* Agents assuming different roles. A patient agent acting on behalf of a human may solicit data from data acquisition agents, i.e., those gathering data from sensors in the patient environment. Upon negotiation of the data acquisition terms, sensor agents may periodically send data to the patient agent, which can then construct its own trajectory, which will be part of its own beliefs. Then, an aggregator agent may request, through a negotiation protocol, data to several patient agents. To accept or reject this request, the different privacy regulations and preferences, as well as usage and consent information, are fundamental. Patient agents agreeing to aggregate their data, will probably expect further processing to produce actionable feedback. Precisely, a processing agent may then use the aggregated trajectories to create (e.g., prediction) models using ML techniques. The outcomes of the processing of patient trajectories can then be used by a coaching agent to provide support and recommendations to the patients that initially contributed their data.

As can be seen, this conceptual architecture emphasizes on the decentralized nature of patient trajectory interactions. *τ* Agents can respond to entirely different goals, even leading to potential conflicts that would require negotiation to be solved. Moreover, the approach also encourages support for different levels of commitment within the agent environment. This responds to the personalized requirements of patient support systems. For example, cancer survivors may have different levels of adherence to treatment and very different illness pathways.

Interactions among *τ* Agents can be embedded in standard agent protocols such as FIPA \[[@CR1]\]. For example, as seen in Fig. [6](#Fig6){ref-type="fig"}, a coaching agent may require prediction results from a processing agent, regarding potential outcomes of a given patient. This request can be encoded as a Request Interaction Protocol, to which the processing agent may agree or refuse. In case of acceptance, the prediction data can be transmitted. All interactions are encoded in RDF in the proposed architecture. Fig. 6*τ* Agent interaction following the FIPA request interaction protocol

Cancer survivors support with *τ* Agents {#Sec6}
========================================

To illustrate the different interactions among *τ* Agents, we present excerpts of semantically annotated data representing excerpts and parts of patient trajectories, for the case scenario of colorectal cancer survivors.

Consider a patient who has survived colon cancer and is now following a long-life support program. His patient agent is in charge of managing his patient trajectory, and for this purpose, it collects EHR information available from agents representing the different hospitals and clinics where he was treated. Moreover, and assuming that the support program includes the usage of wearable devices that monitor physical activity, stress, and behavior, the patient trajectory can be completed with live data integrated continuously. Listing 1Example of symptoms encoded with ICD-10 and following schema.org represented in RDF Turtle format. All prefixes omitted for brevityListing 2Example of colorectal cancer details described with schema.orgListing 3Example of a medical condition --anxiety-- for a cancer survivor

![Example of potential therapies for a cancer survivor --flexibility exercises and psychological group therapy](10916_2020_1620_Figd_HTML){#Figd}

In Listing [1](#Fig1){ref-type="fig"}, we illustrate how we can represent a set of symptoms from a patient, using the schema.org vocabulary. In the example, the patient symptoms are encoded as MedicalSymptom instances, with codes referring to a specific medical coding system (in this case, the ICD-10 standard). These symptoms, i.e., fatigue, rectal bleeding, and diarrhea, can be integrated as part of the patient trajectory and could be used later for stratification or classification.

The symptomatic and diagnosis information is only one small part of the patient trajectory. Additional information can be appended, including the colon cancer diagnose itself (Listing [2](#Fig2){ref-type="fig"}), treatments such as a colonoscopy, epidemiology, risk factors, stage of cancer, etc. Many of these pieces of information can be used in different ways during a support program. Just as an example, considering that risk factors such as polyps or smoking habits can be linked to future recurrence of cancer, the coaching agent may choose to propose actions that reduce those risks. Notice that we can use different coding systems, as in the case of risk factors, where the MeSH \[[@CR32]\] standard is employed.

Furthermore, during the program, a cancer survivor may suffer not only from physical problems but also from psychological issues. As an example, consider that the patient suffers from anxiety, mainly due to the fact of having fear of recurrence. Using a self-reported questionnaire (e.g., through a mobile app), or supported by wearable devices that compute stress levels, and anxiety symptom can be established, encoded with ICD-10 in Listing [3](#Fig3){ref-type="fig"}.

Having this information, the coaching agent can propose actions, in this case potential therapies and activities that could help the patient dealing with his conditions. As an example, in Listing [4](#Fig4){ref-type="fig"} we include both an exercise therapy (flexibility) and psychological therapy (group psychotherapy).

Discussion and related work {#Sec7}
===========================

The proposed conceptual architecture is based on two fundamental ideas: (i) the use of semantic representation models, and (ii) the multi-agent paradigm. Both show complementary properties allowing the establishment of decentralized networks of potentially independent agents, which can establish cooperation and negotiation mechanisms to achieve their goals. Although at this stage, the proposed model does not materialize into an implementation, it already establishes the main guiding principles that should be observed. In particular, we can emphasize on the *τ* Agent basic structure, the types of roles that can be implemented, the usage of RDF for inter-agent communication, the reliance on standard vocabularies such as schema.org, and of medical ontologies like ICD-10 or MeSH. We believe that this approach can lead to promising results, especially for use-cases where patient trajectories can be exploited using large volumes of data while maintaining personal data preferences and guarantees. We identify several aspects in which further research is required in order to address the challenges identified above, and we relate them to existing work in the literature.

Ontology agreement {#FPar13}
------------------

Matching terms among ontologies is a long-studied topic, and in this case, it will be necessary to align concepts from different vocabularies, and even data models \[[@CR25]\]. For example, patient trajectories could be specified both using schema.org and the FHIR[1](#Fn1){ref-type="fn"} specifications. Moreover, a large number of medical specific codes can make it hard to overcome potential coding discrepancies. Several works in the literature have used ontology-based approaches for health data integration \[[@CR17], [@CR30]\]. However, only few works include the modeling of interactions, negotiation, and collaboration among intelligent and autonomous systems \[[@CR11]\], as in *τ* Agents.

Agent autonomy {#FPar14}
--------------

We presented different profiles for *τ* Agents, including specialized sensor data acquisition agents. Nevertheless, given that it is often the case that sensing and wearable devices have limited computation capabilities, it becomes challenging to deploy intelligent agents on such platforms. Although there have been recent proposals on how to adapt multi-agent systems to these environments, e.g., incorporating real-time support \[[@CR12]\] or scheduling strategies \[[@CR13]\], the integration of these data into semantic trajectories remains to be implemented.

Implementation {#FPar15}
--------------

The implementation of the proposed agent-based model is one of the key aspects to consider in the immediate future. This implementation will need to consider the communication interactions as described earlier in the paper and using ontologies such as schema.org as a first-class citizen. Nevertheless, given the open nature of semantic vocabularies, it is at the same time advantageous for extensibility purposes, but problematic as the number of models to integrate can be incompatible or hard to align. The implementation will also consider the issues of agent discovery, negotiation implementation, and publishing patient trajectories. Previous works have explored the integration of health agents through semantic services \[[@CR11]\] and ontology-based approaches \[[@CR23], [@CR40]\], although lacking the concept of patient trajectories.

Recommendation & support {#FPar16}
------------------------

The proposed architecture serves as a platform for eHealth support. Therefore, the high-level challenge is to provide useful recommendations and advice. We plan to implement the use-case for cancer survivors, following the principles and examples shown in this paper. Beyond existing works in the area, including eHealth support and Semantic Web architectures for patient support \[[@CR5], [@CR23]\], we combine both the modelling of trajectories and of agents' behaviors. An additional challenge will be to effectively assess the adequacy and accuracy of the recommendation with respect to the survivors' needs, goals, and expectations.

Explainability {#FPar17}
--------------

A general challenge regarding data analytics, and especially when using ML techniques, is explainability. This is even more important in eHealth, where decisions can have vital consequences. In this case, future work should also consider not only the of symbolic knowledge from ML predictors but also the integration of heterogeneous knowledge and negotiation among explainability agents \[[@CR15]\]. Agents may need to have reliable explanations of analysis and decisions taken regarding a trajectory, before choosing a behavior change strategy \[[@CR2]\].

Evaluation and validation {#FPar18}
-------------------------

Several indicators must be considered for evaluation of this approach, including not only performance metrics for communication and decision making but also considering the effectiveness of negotiations, accuracy of data analytics, response time of agent interactions, compliance to privacy policies, etc. While a number of ontology-based medical system have been evaluated in the last decade \[[@CR28], [@CR35], [@CR37], [@CR40]\], the incorporation of trajectory and agent-based modelling requires a thorough assessment, e.g. by running pilot studies.

Conclusions {#Sec8}
===========

In this paper, we presented a novel approach based on multi-agent systems for managing patient trajectories, which are represented and exchanged using semantic models. We identified first a set of challenges in this context, for which we proposed a corresponding set of design principles. In turn, these principles guide our proposal for a conceptual architecture that defined what we call *τ* Agents, which can assume different roles. Furthermore, we exemplified how this architecture can be used to acquire patient trajectory data, aggregate them, and apply AI algorithms to provide input for coaching agents. The entire concept has been used to illustrate a concrete use-case, i.e., for cancer survivorship support. Finally, we have proposed a research agenda that continues addressing the different challenges described in the paper, targeting not only scientific but also societal impact through the development of decentralized eHealth applications.
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